Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale Chief Executive Officer sold 85,906 shares at an average $84.66 ($7,272,904)
  2. 4 Open-market sale CMO, Hematology sold 1,600 shares at an average $86.25 ($138,000)
  3. 4 Open-market sale Chief Executive Officer sold 150,957 shares at an average $80.50 ($12,152,374)
  4. 4 Open-market sale CMO, Immuno-oncology sold 3,601 shares at an average $82.96 ($298,747)
  5. 4 Other disposition Director disposed of 49,200 shares (other)
  6. 4 Grant or award Chief Executive Officer acquired 515,000 shares (grant or award)
  7. 4 Grant or award Director acquired 410,000 shares (grant or award)
  8. 4 Shares withheld for taxes CMO, Immuno-oncology gave up 28,185 shares (to pay taxes)
  9. 4 Open-market buy Director bought 176,056 shares at $71.00 ($12,499,976)
  10. 4 Open-market sale Director sold 20,000 shares at an average $72.44 ($1,448,704)
  11. 4 Open-market sale Director sold 10,810 shares at an average $72.15 ($779,900)
  12. 4 Open-market sale Chief Executive Officer sold 219,400 shares at an average $64.82 ($14,221,125)
  13. 4 Open-market sale Director sold 35,000 shares at an average $44.95 ($1,573,345)
  14. 4/A Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Executive Officer sold 98,500 shares at an average $44.16 ($4,349,622)
  20. 4 Derivatives Options or other derivatives

Page 26 of 29 · 580 filings